SCHEMBL784203

SCHEMBL784203

CN(C(=O)c1ccc2c(c1)[C@H](NC(=O)c1ccccc1Cl)CCC2)C1CCN(c2ccncc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
CTSS P25774 2/20 0.47
TAS1R3 Q7RTX0 6/20 0.45
TAS1R1 Q7RTX1 6/20 0.45
TAS1R2 Q8TE23 6/20 0.45
KDM4E B2RXH2 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
BDKRB1 P46663 3/20 0.40
TAOK1 Q7L7X3 1/20 0.40
TAOK3 Q9H2K8 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784227 1.00 ALDH1A1 (0.51) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL784261 0.95 ALDH1A1 (0.43) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL784081 0.95 ALDH1A1 (0.43) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL777867 0.95 ALDH1A1 (0.43) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL784955 0.94 TAS1R3 (0.44) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL785754 0.94 ALDH1A1 (0.43) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL784390 0.91 CTSS (0.42) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL784085 0.91 ALDH1A1 (0.42) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2
SCHEMBL785511 0.89 TAS1R3 (0.52) ALDH1A1CTSSTAS1R3TAS1R1KDM4E
SCHEMBL785705 0.89 TAS1R3 (0.41) ALDH1A1CTSSTAS1R3TAS1R1TAS1R2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US claimed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US claimed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 ALDH1A1 1267/4885CTSS 824/4885TAS1R3 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.